2007
DOI: 10.1016/j.neuroscience.2006.11.059
|View full text |Cite
|
Sign up to set email alerts
|

Genistein inhibits glutamate-induced apoptotic processes in primary neuronal cell cultures: An involvement of aryl hydrocarbon receptor and estrogen receptor/glycogen synthase kinase-3β intracellular signaling pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
55
0

Year Published

2008
2008
2020
2020

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 60 publications
(57 citation statements)
references
References 47 publications
2
55
0
Order By: Relevance
“…It is important to note that in the present study, despite the long incubation time, the drugs were used at low concentrations. Because protein trafficking takes time, it is appropriate to use the long term treatment in our study, which is actually consistent with many previous studies successfully using long term drug treatment to alter actin cytoskeleton, lipid rafts, and tyrosine phosphorylation (51)(52)(53)(54)(55).…”
Section: Journal Of Biological Chemistrysupporting
confidence: 85%
“…It is important to note that in the present study, despite the long incubation time, the drugs were used at low concentrations. Because protein trafficking takes time, it is appropriate to use the long term treatment in our study, which is actually consistent with many previous studies successfully using long term drug treatment to alter actin cytoskeleton, lipid rafts, and tyrosine phosphorylation (51)(52)(53)(54)(55).…”
Section: Journal Of Biological Chemistrysupporting
confidence: 85%
“…Apigenin consistently did not increase AMPK and ACC phosphorylations in HepG2 cells (Zang et al, 2006). Genistein protects cells at 0.1 to 40 M (Kajta et al, 2007;Kim et al, 2007), but the compound activates AMPK in adipocytes at 50 to 200 M (Hwang et al, 2005). Hence, its beneficial effect may not result from AMPK activation.…”
Section: Parp-lkb1-dependent Mitochondrial Protection 893mentioning
confidence: 90%
“…Genistein, a phytoestrogen, protects SH-SY5Y cells (Bang et al, 2004) as well as cultured hippocampal neurons (Zeng et al, 2004) from A␤ toxicity. However, in addition to its action on estrogen receptors, genistein is also a general tyrosine kinase inhibitor that protects cultured neurons from L-glutamate toxicity (Kajta et al, 2007). Genistein enhances the amplitude of ACh responses when human ␣7 nAChRs are expressed in Xe- FIG.…”
Section: B Nicotinic Receptor-mediated Neuroprotection: a Particularmentioning
confidence: 99%
“…The potentiating effect of genistein on AChevoked responses did not involve a large shift in the EC 50 for ACh (Grønlien et al, 2007). Thus, although an involvement of estrogen receptors has been demonstrated for the protective action of genistein (Kajta et al, 2007), it is tempting to speculate that the neuroprotective effect of genistein may also involve, at least in part, the enhancement of nAChR function through the inhibition of tyrosine kinase action upon nAChRs. In support of this notion, ␤-estradiol protects PC12 cells from amyloid toxicity, and this is prevented when ␣7 nAChRs are blocked with methyllycaconitine (Svensson and Nordberg, 1999).…”
Section: Nicotinic Acetylcholine Receptors and Alzheimer's Diseasementioning
confidence: 99%